Aardvark Therapeutics, Inc. (AARD) is a Health Care company in the Pharmaceutical Preparations industry (SEC CIK 0001774857). Annual revenue was $0.00B in FY2025. Net income in FY2025 was $-0.06B (diluted EPS $-2.93).
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 |
|---|---|---|---|
| Revenue | $0.00B | — | — |
| Gross Profit | — | — | — |
| Operating Income | $-0.06B | $-0.02B | — |
| Net Income | $-0.06B | $-0.02B | — |
| EPS (Diluted) | $-2.93 | $-5.15 | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 |
|---|---|---|---|
| Total Assets | $0.12B | $0.08B | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 |
|---|---|---|---|
| Operating Cash Flow | $-0.05B | $-0.02B | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 |
|---|---|---|---|
| Gross Margin | — | — | — |
| Operating Margin |
Showing the most recent 3 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001193125-26-224069 | May 14, 2026 | May 14, 2026 | May 14, 2026 20:15 UTC | EDGAR |
| 8-K | 0001193125-26-210664 | May 7, 2026 | May 7, 2026 | May 7, 2026 13:28 UTC | EDGAR |
| 10-Q | 0001193125-26-210675 | Mar 31, 2026 | May 7, 2026 | May 7, 2026 13:32 UTC | EDGAR |
| 8-K | 0001193125-26-120164 | Mar 23, 2026 | Mar 24, 2026 | Mar 23, 2026 22:30 UTC | EDGAR |
| 8-K | 0001193125-26-119727 | Mar 23, 2026 | Mar 23, 2026 | Mar 23, 2026 20:09 UTC | EDGAR |
| 10-K | 0001193125-26-119770 | Dec 31, 2025 | Mar 23, 2026 | Mar 23, 2026 20:19 UTC | EDGAR |
| 8-K | 0001193125-26-082787 | Feb 27, 2026 | Feb 27, 2026 | Feb 27, 2026 21:27 UTC | EDGAR |
| 8-K | 0001193125-26-047757 | Feb 9, 2026 | Feb 12, 2026 | Feb 12, 2026 13:17 UTC | EDGAR |
Direct links to SEC EDGAR. AARD has additional filings available on the SEC site.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| Total Liabilities | $0.01B | $0.01B | — |
|---|
| Stockholders' Equity | $0.11B | $-0.05B | $-0.03B |
|---|
| Cash & Equivalents | $0.05B | $0.06B | $0.01B |
|---|
| Total Debt | — | — | — |
|---|
| Capital Expenditures | $0.00B | $0.00B | — |
|---|
| Free Cash Flow | $-0.05B | $-0.02B | — |
|---|
| — |
| — |
| Net Margin | — | — | — |
|---|
| Return on Equity | -54.0% | 37.7% | — |
|---|
| Return on Assets | -49.1% | -26.6% | — |
|---|
| Debt / Equity | 0.10× | — | — |
|---|
